Skip to main
CVRX

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

CVRx Inc reported a significant increase in its operational capabilities, as evidenced by the growth in active implanting centers, which rose by 13 to reach a total of 240 at the end of the quarter. Despite a year-over-year increase of approximately 8% in total operating expenses to $25.8 million, the majority of this increment was attributed to rising selling, general, and administrative costs, which went up by around 11% to $23.4 million. The company's focus on expanding its global footprint in the United States market for its innovative Baroreflex Activation Therapy positions it favorably for future revenue growth amid growing demand for its neuromodulation solutions.

Bears say

CVRx has recently lowered its FY25 revenue guidance from a prior range of $55.0 - $58.0 million to a new range of $55.0 - $57.0 million, reflecting a subdued growth rate of approximately 7-11% year-over-year. The company also reduced its revenue estimate for 2026 from $74.1 million to $67.6 million, indicating expectations for a slower ramp-up in the U.S. market. Additionally, the gross margin remained flat at 84% for the second quarter of 2025, suggesting limited operational leverage and potential challenges in improving profitability.

CVRx (CVRX) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 5 analysts, CVRx (CVRX) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.